This strategy is designed to reinforce national medicines policies and
existing tools and guidelines such as essential medicines lists and
standard treatment guidelines. It also examines such issues as
sustainable financing and pricing mechanisms and analyses the effects of
trade globalization and the Agreement on Trade-Related Aspects of
Intellectual Property Rights (TRIPS agreement). It proposes strategic
options and actions to improve access to essential medicines.